Hepatoprotective Potential of Indian Medicinal Plants
Authors: Kumari Arti , Chandila Nisha , Bhutani Rubina , Yadav Inderjeet 
Published: January 2025

Introduction:

The liver is essential for both the body's removal of waste materials and the metabolism
of nutrients, it is critical for sustaining general health. However, a number of factors, including viral
infections, immune system malfunctions, cancer, alcohol intake, and drug toxicity, are contributing to the rising
prevalence of liver problems. Alternative approaches to liver disease treatment are being investigated due
to the potential limitations of conventional medical treatments. In this regard, the possible hepatoprotective
effects of medicinal plants containing bioactive chemicals high in antioxidants have drawn attention.

Method:

This review's objective is to provide an overview of the Indian medicinal plants' therapeutic value.
A variety of databases, including PubMed, Web of Science, Scopus, Academic Journals Embase, Google
Scholar, and Science Direct, were searched for relevant literature using keywords such as "hepatoprotective,"
"hepatotoxins," "medicinal plants," and "phytoconstituents".

Result:

This article focuses on plant-based medicines that guard against oxidative stress and pollutants, highlighting
the potential of herbal remedies as alternatives to traditional liver disease treatments. Reviewing the
hepatoprotective qualities of a number of medicinal plants, such as Ginkgo biloba, Woodfordia fruticosa,
Thymus quinquecostatus, and Terminalia arjuna, offer more details about their effectiveness.
Terminalia arjuna: Preclinical research demonstrates a 30-40% decrease in liver enzyme levels and a 50-60%
rise in antioxidant indicators; clinical trials reveal a 25-30% decrease in liver enzyme levels.
Thymus quinquecostatus: Research on animals shows a 35-45% decrease in liver enzymes, and preliminary
clinical findings indicate a 20-30% improvement in liver function.
Woodfordia fruticosa: Although clinical evidence is not as strong as preclinical trials, early investigations indicate
a 25-35% improvement in liver enzymes and a 50-60% reduction in liver damage indicators.
Ginkgo biloba: Shown enhanced liver function and a 40-50% decrease in liver enzymes; clinical trials have
also shown improvements in liver enzymes and a 20-30% decrease in fibrosis markers in NAFLD patients.

Conclusion:

In conclusion, the increased prevalence of liver diseases emphasizes the necessity for nonconventional
therapeutic options. Medicinal plants, as opposed to conventional medicines, have promising
hepatoprotective effects with fewer adverse effects since they include bioactive substances such as sterols,
anthocyanins, terpenoids, saponin glycosides, and polyphenolics. Clinical trials have shown the potential of
some plant medications to support liver health.
For example, clinical trials have demonstrated the effectiveness of Picrorhiza kurroa in treating liver disorders
including viral hepatitis, with a notable decrease in liver enzyme levels. Xanthones found in Garcinia
mangostana have been shown in preclinical and clinical trials to have liver-protective qualities, enhancing
liver function and lowering oxidative stress indicators. Clinical research has demonstrated that citrus medica
helps people with liver problems by reducing inflammation and improving liver function. Anthocyanin-rich
Vaccinium myrtillus (Bilberry) has been shown to lower oxidative stress and enhance liver enzyme profiles
in fatty liver disease patients.
These plant-based medicines can greatly enhance the treatment arsenal for liver ailments by addressing the underlying
causes and symptoms of liver diseases. In order to substantiate their role in hepatoprotection, future research
should concentrate on verifying these findings through additional clinical trials.